Literature DB >> 2786978

Induction of anticentromere antibody in patients receiving treatment with D-penicillamine.

G Haberhauer1.   

Abstract

Anticentromere antibody (ACA) was previously described as a specific marker for CREST, progressive systemic sclerosis (PSS), scleroderma (SCL), Raynaud's phenomenon (RP) and primary biliary cirrhosis (PBC). In this present investigation ACA was observed appearing and disappearing due to D-penicillamine (DPA) treatment in 7 patients without any features of CREST, PSS, SCL, RP or PBC. HLA-DR3 was found in 5/7 of these patients. DPA induced ACA should be added to adverse immunologic drug reactions.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2786978     DOI： 10.1007/bf01719779

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  18 in total

1.  Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.

Authors:  E S Weiner; W C Earnshaw; J L Senécal; B Bordwell; P Johnson; N F Rothfield
Journal:  Arthritis Rheum       Date:  1988-03

2.  Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.

Authors:  V D Steen; D L Powell; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-02

3.  Anticentromere antibody in primary biliary cirrhosis.

Authors:  R M Bernstein; M E Callender; J M Neuberger; G R Hughes; R Williams
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

4.  [CRST syndrome and primary biliary cirrhosis].

Authors:  G Haberhauer; G Wandner; E Machacek; H Bröll
Journal:  Z Rheumatol       Date:  1987 Nov-Dec       Impact factor: 1.372

5.  Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.

Authors:  V D Steen; G L Ziegler; G P Rodnan; T A Medsger
Journal:  Arthritis Rheum       Date:  1984-02

6.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

7.  The CREST syndrome: a distinct serologic entity with anticentromere antibodies.

Authors:  M J Fritzler; T D Kinsella
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

Authors:  E M Tan; G P Rodnan; I Garcia; Y Moroi; M J Fritzler; C Peebles
Journal:  Arthritis Rheum       Date:  1980-06

9.  Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.

Authors:  G A McCarty; J R Rice; M L Bembe; F A Barada
Journal:  Arthritis Rheum       Date:  1983-01

10.  Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.

Authors:  J P Camus; J C Homberg; J Crouzet; C Mery; F Delrieu; P Massias; N Abuaf
Journal:  J Rheumatol Suppl       Date:  1981 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.